These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10504695)

  • 1. Tumor angiogenesis--new drugs on the block.
    Brower V
    Nat Biotechnol; 1999 Oct; 17(10):963-8. PubMed ID: 10504695
    [No Abstract]   [Full Text] [Related]  

  • 2. Metronomic chemotherapy: teaching old drugs new tricks?
    Vogelzang N
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):432-3. PubMed ID: 16163217
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrins: the keys to unlocking angiogenesis.
    Silva R; D'Amico G; Hodivala-Dilke KM; Reynolds LE
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1703-13. PubMed ID: 18658045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Targeting angiogenesis in oncology].
    Fayette J; Soria JC; Armand JP
    Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
    Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM
    Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global development of angiogenesis inhibitors for cancer: principles, progress and new paradigms.
    Li WW; Li VW; Brainerd N; Fagen SJ
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():50-8. PubMed ID: 11890115
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target?
    Rüegg C; Dormond O; Foletti A
    Endothelium; 2002; 9(3):151-60. PubMed ID: 12380640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of commonly used drugs on angiogenesis.
    Sartippour MR; De Leon E; Rubio R; Brooks MN
    Anticancer Res; 2003; 23(1A):231-4. PubMed ID: 12680218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis as a therapeutic target.
    Ferrara N; Kerbel RS
    Nature; 2005 Dec; 438(7070):967-74. PubMed ID: 16355214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecules in anti-angiogenic therapy.
    Giavazzi R; Nicoletti MI
    Curr Opin Investig Drugs; 2002 Mar; 3(3):482-91. PubMed ID: 12054101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis inhibitors in cancer therapy.
    Dredge K; Dalgleish AG; Marriott JB
    Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiogenesis inhibitors and radiation therapy: concept and preliminary results].
    Mazeron R; Bourhis J; Deutsch E
    Bull Cancer; 2009 Mar; 96(3):299-310. PubMed ID: 19318308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular mechanisms of angiogenesis.
    Maciag T
    Important Adv Oncol; 1990; ():85-98. PubMed ID: 1691138
    [No Abstract]   [Full Text] [Related]  

  • 15. Thymosin {beta}(10) inhibits angiogenesis and tumor growth by interfering with Ras function.
    Lee SH; Son MJ; Oh SH; Rho SB; Park K; Kim YJ; Park MS; Lee JH
    Cancer Res; 2005 Jan; 65(1):137-48. PubMed ID: 15665289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.
    Funahashi Y; Sugi NH; Semba T; Yamamoto Y; Hamaoka S; Tsukahara-Tamai N; Ozawa Y; Tsuruoka A; Nara K; Takahashi K; Okabe T; Kamata J; Owa T; Ueda N; Haneda T; Yonaga M; Yoshimatsu K; Wakabayashi T
    Cancer Res; 2002 Nov; 62(21):6116-23. PubMed ID: 12414636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the study of mechanisms of the tumor angiogenesis inhibitors].
    Xiao D; Ding J
    Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):219-23. PubMed ID: 12532783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis inhibitors. New anticancer strategy.
    Zgodziński W; Wallner G; Dabrowski A
    Pol J Pharmacol; 1999; 51(6):455-62. PubMed ID: 10817522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of integrins in tumor angiogenesis.
    Hwang R; Varner J
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):991-1006, vii. PubMed ID: 15474331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.